ASP015K: A Novel Janus Kinase Inhibitor Demonstrated Potent Efficacy in Adjuvant-Induced Arthritis and Chronic Oxazolone-Induced Dermatitis Model in Rats

被引：0
|
作者：
Inami, Masamichi [1 ]
Yamazaki, Shunji [1 ]
Ito, Misato [1 ]
Chida, Noboru [1 ]
Nakanishi, Tomonori [1 ]
Ooshima, Shinsuke [1 ]
Hanaoka, Kaori [1 ]
Ohkubo, Keiko [1 ]
Shirakami, Shohei [1 ]
Inoue, Takayuki [1 ]
Fujii, Yasutomo [1 ]
Higashi, Yasuyuki [1 ]
机构：
[1] Astellas Pharma Inc, Pharmacol Res Labs, Tsukuba, Ibaraki 3058585, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2013年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：47P / 47P
页数：1
相关论文
共 35 条
  • [1] ASP015K: A NOVEL JAK INHIBITOR DEMONSTRATED POTENT EFFICACY IN ADJUVANT-INDUCED ARTHRITIS MODEL IN RATS
    Yamazaki, S.
    Morio, H.
    Inami, M.
    Ito, M.
    Fujii, Y.
    Hanaoka, K.
    Yamagami, K.
    Okuma, K.
    Morita, Y.
    Shirakami, S.
    Inoue, T.
    Miyata, S.
    Higashi, Y.
    Seki, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 197 - 197
  • [2] ASP015K: A Novel JAK Inhibitor Demonstrated Potent Efficacy in Adjuvant-Induced Arthritis Model in Rats
    Yamazaki, Shunji
    Inami, Masamichi
    Ito, Misato
    Fujii, Yasutomo
    Hanaoka, Kaori
    Yamagami, Kaoru
    Okuma, Kenji
    Morita, Yoshiaki
    Shirakami, Shohei
    Inoue, Takayuki
    Miyata, Susumu
    Higashi, Yasuyuki
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S882 - S882
  • [3] Inhibition of STAT5-phosphorylation and Efficacy in a Rat Arthritis Model with ASP015K, a Novel Janus Kinase Inhibitor
    Higashi, Yasuyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 71P - 71P
  • [4] PHARMACODYNAMICS OF ASP015K, A NOVEL JANUS KINASE INHIBITOR, IN HEALTHY VOLUNTEERS
    Zhu, T.
    Valluri, U.
    Lewand, M.
    Cao, Y.
    Cho, K.
    Holman, J.
    Sawamoto, T.
    Keirns, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 252 - 252
  • [5] Effects of the Janus Kinase Inhibitor CP-690550 (Tofacitinib) in a Rat Model of Oxazolone-Induced Chronic Dermatitis
    Fujii, Yasutomo
    Sengoku, Takanori
    PHARMACOLOGY, 2013, 91 (3-4) : 207 - 213
  • [6] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ASP015K, A NOVEL JANUS KINASE INHIBITOR, IN HEALTHY VOLUNTEERS
    Zhu, T.
    Sawamoto, T.
    Valluri, U.
    Lewand, M.
    Cao, Y.
    Swan, S.
    Lasseter, K.
    Matson, M.
    Holman, J.
    Keirns, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 898 - 899
  • [7] A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model
    Ito, Misato
    Yamazaki, Shunji
    Yamagami, Kaoru
    Kuno, Masako
    Morita, Yoshiaki
    Okuma, Kenji
    Nakamura, Koji
    Chida, Noboru
    Inami, Masamichi
    Inoue, Takayuki
    Shirakami, Shohei
    Higashi, Yasuyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (01) : 25 - 33
  • [8] COADMINISTRATION OF ASP015K, A NOVEL JANUS KINASE INHIBITOR, WITH METHOTREXATE DEMONSTRATES TOLERABILITY AND LACK OF PHARMACOKINETIC INTERACTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Zhu, T.
    Oda, K.
    Valluri, U.
    Moore, B.
    Cao, Y.
    Chindalore, V.
    Akinlade, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 898 - 898
  • [9] Identification and characterization of metabolites of ASP015K, a novel oral Janus kinase inhibitor, in rats, chimeric mice with humanized liver, and humans
    Nakada, Naoyuki
    Oda, Kazuo
    XENOBIOTICA, 2015, 45 (09) : 757 - 765
  • [10] CHLAMYDIA TRACHOMATIS IS A POTENT INHIBITOR OF ADJUVANT-INDUCED ARTHRITIS IN DA RATS
    WOODS, ML
    CANNON, GW
    GRIFFITHS, MM
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S330 - S330
1234